menna.sadik1652

منه الله حسن صديق السيد

Teadching-Assistant -

Faculty of medicine

Address: Sohag, Egypt

0

Like


                                                              Personal data

NAME: Mennaallah Hassan Seddik Alsayed
NATIONALITY: Egyptian
DATE OF BIRTH: 30th September 1987
PLACE OF BIRTH: Sohag, Egypt
MARITAL STATUS: Married
                                                 Personal Contact Information

Mobile phone: +81 09092051573
E-mail: menna_alesawy@ymail.com
           menna.sadik@med.sohag.edu.eg
Current Employment: Assistant lecturer of Clinical Oncology, Sohag University Hospital, Faculty of                                            Medicine, Sohag University, Egypt (2016).
                                                         Academic degrees

Bachelor in Medicine and Surgery (May 2010):
    With grade Excellent with Honor (85.63%), Faculty of medicine, Sohag University.

Master Degree in clinical oncology (December 2015):
   With grade very good B+, Department of Clinical Oncology and Nuclear Medicine Faculty of medicine,       Sohag University

                                                                 positions

1. Resident physician at clinical oncology dep., Sohag Unversity hospital between 2012-2015.

2. Visiting researcher at radiation oncology department at kanazawa University hospital, Ishikawa, Japan      between June 2014 - April 2015

3. Teaching assisstant at at clinical oncology dep., Sohag Unversity from 2016

4. Currently, MEXT scholarship student at radiation oncology dep., Kobe University, Japan, from Oct. 2017 

 

                                                               Experiences

1- Training at clinical oncology dep., Sohag Unversity hospital (treatment with chemotherapy and radiotherapy) as a resident physician between 2012-2015.
2- Training at radiation oncology department at kanazawa University hospital, Ishikawa, Japan on 3DCRT,  IMRT, low and high dose rate brachytherapy between June 2014 - April 2015.


2020-06-13 12:47:22 | Keywords nanoparticlesnon-cytotoxic,
A Comparative Assessment of Mechanisms and Effectiveness of Radiosensitization by Titanium Peroxide and Gold Nanoparticles
The development of potentially safe radiosensitizing agents is essential to enhance the treatment outcomes of radioresistant cancers. The titanium peroxide nanoparticle (TiOxNP) was originally produced using the titanium dioxide nanoparticle, and it showed excellent reactive oxygen species (ROS) generation in response to ionizing radiation. Surface coating the TiOxNPs with polyacrylic acid (PAA) showed low toxicity to the living body and ... Read more

2020-06-13 13:08:10 | Keywords head and neck cancer; radiati,
Oral Complications Following Radiation Therapy for Head and Neck Malignancy
Each year, head and neck cancer comprises more than 550,000 cases and contributes to 380,000 deaths, worldwide. Radiation Therapy (RT) is used for head and neck cancers as definitive, adjuvant, or palliative treatment. The most important advantage of RT, compared with surgery, is function preservation; however, normal tissue complications occur during (acute complications) or after (subacute and chronic complications) RT ... Read more

Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study
3-Bromopyruvate (3BP) is a new, promising anticancer alkylating agent with several notable functions. In addition to inhibiting key glycolysis enzymes including hexokinase II and lactate dehydrogenase (LDH), 3BP also selectively inhibits mitochondrial oxidative phosphorylation, angiogenesis, and energy production in cancer cells. Moreover, 3BP induces hydrogen peroxide generation in cancer cells (oxidative stress effect) and competes with the LDH substrates pyruvate ... Read more